Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A ( LY3509754 ): A Phase I Randomized Placebo‐Controlled Study

Documenti analoghi

• Identification of a Safe and Tolerable Carbamazepine Dosing Paradigm that Facilitates Effective Evaluation of CYP3A4 Induction
  di: Amita Datta‐Mannan, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants
  di: Rolf Pokorny, et al.
  Pubblicazione: (2025)
• Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study
  di: Junyu Xu, et al.
  Pubblicazione: (2025)
• Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open‐Label Study
  di: Amita Datta‐Mannan, et al.
  Pubblicazione: (2025)
• From street to job: integrating juvenile delinquents
  di: Isabelle Coutant
  Pubblicazione: (2010)